On the domestic Ai Ke Saier Cypher drug-eluting stent with drug-eluting stents bare-metal stents in percutaneous coronary intervention near mid-term comparison of efficacy.docVIP

 PAGE \* MERGEFORMAT 15 On the domestic Ai Ke Saier Cypher drug-eluting stent with drug-eluting stents bare-metal stents in percutaneous coronary intervention near mid-term comparison of efficacy Author: Fan Hongjie Wu Haiyan, Sun Ke-li Dong Du Hua Xu Chunyan this Fan Yulin Qin Han Xueling [Paper Keywords:] Coronary artery disease; Angioplasty, percutaneous coronary; stent; restenosis [Abstract] Objective: To investigate the drug-eluting stents made Love Ke Saier, import Cypher drug-eluting stents, bare-metal stent in the treatment of acute myocardial infarction (AMI) or unstable angina (UA) differences in clinical efficacy. Methods: 126 patients in our hospital-line PCI in patients with coronary artery disease were divided into three groups, Love Ke Saier drug-eluting stent group (65 cases), import Cypher drug-eluting stent group (36 cases), bare-metal stent group ( 25 cases), analysis 6 months after stent placement of the stent thrombosis rate and 6-month restenosis rate. Results: Three patients in the postoperative patency, cardiac function and cardiac events in the hospital was no significant difference, 6 to 8 months after the follow-up, no stent thrombosis, domestic Love Ke Saier drug-eluting stent group of in-stent restenosis rate was 5.9%; imports of Cypher drug-eluting stent group of in-stent restenosis rate was 3.7%; the bare stent group of in-stent restenosis rate was 33.3%. Conclusion: Domestic Love Ke Saier drug-eluting stents, Cypher drug-eluting stent in the treatment of imports in patients with AMI did not increase within 6 months the incidence of stent thrombosis, restenosis rate difference was not statistically significant; with bare stents The two 6-month restenosis rate was significantly reduced. The emergence of drug-eluting stent percutaneous coronary intervention (PCI) milestone, a large number of studies have shown that drug-eluting stents can make in-stent restenosis rate has dropped to less than 10% [1],